评估癌症诊断后老年患者出现并发症的风险
Md Tamzid Islam1, Md Saiful Islam Saif1, Naima Alam1
1Department of Biostatistics & Data Science, The University of Kansas Medical Center, Kansas City, KS, 66160, USA.
BMC public health
|February 18, 2025
概括
与没有癌症的患者相比,癌症患者患伴随疾病的几率要高得多. 这凸显了在癌症治疗期间需要综合护理,重点关注患者整体健康.
科学领域:
- 老年学是一门学科.
- 在瘤学瘤学.
- 公共卫生 公共卫生
背景情况:
- 癌症显著影响患者的身体,精神和社会福祉.
- 老年癌症患者特别容易患上并发症.
- 现有的国家研究缺乏全面的统计方法来评估癌症患者的并发症发展.
研究的目的:
- 解决国家一级统计技术的差距,以评估癌症的并发症发展.
- 为了比较癌症与非癌症患者的并发症发生率在四年内.
主要方法:
- 利用了来自健康退休研究 (HRS) 50岁以上的6651名参与者的数据.
- 进行了为期4年的纵向分析,以确定并发症的发展 (例如高血压,糖尿病,心脏病,中风,肺部疾病,心理障碍).
- 使用多变量回归和倾向得分匹配 (1:3) 来调整社会经济因素并比较癌症和非癌症组.
主要成果:
- 与非癌症患者相比,癌症患者患上并发症的可能性显著更高 (OR=1.321,p=0.0051),即使在调整了社会经济因素之后.
- 倾向性得分匹配证实癌症患者的并发症发展显著更高 (OR=1.294,p=0.0207).
- 发现社会经济因素与癌症及其对伴随性疾病的影响有显著关联.
结论:
- 这些发现强调了加强癌症治疗方案的必要性,以解决患者的整体健康问题.
- 优先考虑综合护理可以降低癌症患者患其他疾病的易感性.
- 这项研究强调了在癌症幸存率和护理计划中考虑并发症的重要性.
相关概念视频
01:19Psychoneuroimmunology: Diabetes and Cancer
21
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
21
02:59Cancer Prevention
6.0K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.0K
01:21Cancer Survival Analysis
321
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
321
02:56Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
02:07Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K